Scientists have applied iPS technology to a model of Huntington's disease in transgenic nonhuman primates, allowing them to conveniently assess the efficacy of potential therapies on neuronal cells in the laboratory.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...